Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites.
Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. For avoidance of any doubts and to make it easier, you may consider any links to external websites as sponsored links. Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.


Seyfarth Shaw LLP announced today that Dean Fanelli, Ph.D. and Thomas Haag, Ph.D., co-founders of top intellectual property boutique Fanelli Haag PLLC, have joined Seyfarth as partners in the Litigation department in Washington, D.C.

In addition to Dean and Thomas, the Fanelli Haag team of lawyers and patent agents that has joined Seyfarth includes King Lit Wong, Ph.D., Maria L. Maebius, Parithosh K. Tungaturthi, Ph.D., and Alex Li, Ph.D.

“It is exciting to welcome a group of such respected and well-regarded intellectual property lawyers to Seyfarth who are advising on a variety of leading-edge pharma and other life sciences matters around the globe,” said Kate Perrelli, chair of Seyfarth’s Litigation department.

“Dean and Thomas’ team brings a unique combination of scientific technical expertise and years of legal and life sciences business experience — including many years working in private equity, the bio/pharma industry and with the U.S. Patent and Trademark Office. Their practice includes a full range of services including patent prosecution, counseling, licensing, due diligence, and litigation. They will be a tremendous resource for our clients, and a phenomenal addition to our firm and national IP practice group,” added Brian Michaelis, chair of Seyfarth’s Intellectual Property practice. “This top-flight group of lawyers and scientists immediately strengthens our nationally recognized IP practice and will create new opportunities for growth across the firm.”

“We are very excited to launch Seyfarth’s Life Sciences and Chemical Patent team in Washington, D.C. Due to the high quality of Fanelli Haag’s services, we were being asked by clients to perform increasingly complex transactional work, take on USPTO Post Grant and Inter Partes Review proceedings, and handle associated district court litigation. These are services we are looking forward to providing through Seyfarth which has far greater legal resources than those previously available to us at Fanelli Haag. Joining Seyfarth allows us to continue to serve our clients in the same manner to which they have become accustomed while providing a broader legal platform to more completely attend to their needs,” explained Thomas Haag.

Founded in 2009, Fanelli Haag rose to prominence as a leading intellectual property boutique focused on issues facing the biotechnology, pharmaceutical, nanotechnology and chemical industries. Clients ranged from multinational chemical and pharmaceutical corporations to early-stage nanotechnology and clinical-stage biotech companies, as well as venture capital firms. In 2015, corporate counsel ranked Fanelli Haag as a “Most-Favored IP Boutique — One of the best firms in IP,” according to a report from BTI Consulting Group.

“As we continue to expand our Washington, D.C. office, Dean and Thomas’ team provides an important and sizeable presence for our clients with IP needs, in particular those that require boots on the ground here or before the USPTO,” explained Robert Bodansky, managing partner of Seyfarth’s Washington, D.C. office.